Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
20 April 2024
|
m 00:39 | Classical Hodgkin lymphoma 2 changes history +914 [Jwarner (2×)] | |||
m |
|
00:39 (cur | prev) +69 Jwarner talk contribs | |||
m |
|
00:37 (cur | prev) +845 Jwarner talk contribs |
19 April 2024
m 12:34 | Mantle cell lymphoma diffhist 0 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:b5de78|Regimen=1}} |
18 April 2024
|
m 23:44 | Peripheral T-cell lymphoma 2 changes history +22 [Jwarner (2×)] | |||
m |
|
23:44 (cur | prev) +3 Jwarner talk contribs →References | |||
m |
|
23:44 (cur | prev) +19 Jwarner talk contribs →Gemcitabine monotherapy {{#subobject:7dbc1c|Regimen=1}} |
15 April 2024
m 17:04 | CNS lymphoma diffhist +16 Jwarner talk contribs →Nordic Regimen, younger patients {{#subobject:e571ce|Regimen=1}} |
14 April 2024
|
m 17:21 | Mantle cell lymphoma 2 changes history +35 [Jwarner (2×)] | |||
m |
|
17:21 (cur | prev) +9 Jwarner talk contribs →Preceding treatment | |||
m |
|
17:20 (cur | prev) +26 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} |
m 17:19 | Light-chain (AL) amyloidosis diffhist +24 Jwarner talk contribs →Relapsed or refractory |
m 12:43 | Diffuse large B-cell lymphoma diffhist +355 Jwarner talk contribs |
13 April 2024
|
m 15:29 | Follicular lymphoma 6 changes history +606 [Jwarner (6×)] | |||
m |
|
15:29 (cur | prev) +82 Jwarner talk contribs →Maintenance after subsequent lines of therapy | |||
m |
|
15:27 (cur | prev) +55 Jwarner talk contribs →Consolidation after subsequent lines of therapy | |||
m |
|
15:25 (cur | prev) +227 Jwarner talk contribs →Maintenance after first-line therapy | |||
m |
|
15:22 (cur | prev) +204 Jwarner talk contribs →Consolidation after first-line therapy | |||
m |
|
15:17 (cur | prev) +11 Jwarner talk contribs →Observation | |||
m |
|
15:17 (cur | prev) +27 Jwarner talk contribs →Radiation therapy {{#subobject:6298df|Regimen=1}} |
|
m 15:12 | Diffuse large B-cell lymphoma 5 changes history +574 [Jwarner (5×)] | |||
m |
|
15:12 (cur | prev) +1 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:e4284f|Regimen=1}} | |||
m |
|
15:11 (cur | prev) +230 Jwarner talk contribs →Relapsed or refractory, salvage therapy | |||
m |
|
15:06 (cur | prev) +61 Jwarner talk contribs | |||
m |
|
15:04 (cur | prev) +65 Jwarner talk contribs →Maintenance after upfront therapy | |||
m |
|
15:03 (cur | prev) +217 Jwarner talk contribs →Consolidation after upfront therapy |
|
m 12:54 | CNS lymphoma 6 changes history +587 [Jwarner (6×)] | |||
m |
|
12:54 (cur | prev) +77 Jwarner talk contribs →Relapsed or refractory, salvage therapy | |||
m |
|
12:54 (cur | prev) +285 Jwarner talk contribs →Consolidation after upfront therapy | |||
m |
|
12:51 (cur | prev) +87 Jwarner talk contribs →Upfront therapy, non-randomized or retrospective data | |||
m |
|
12:49 (cur | prev) +107 Jwarner talk contribs →Upfront therapy, randomized data | |||
m |
|
12:47 (cur | prev) +11 Jwarner talk contribs →Methotrexate monotherapy {{#subobject:e89965|Regimen=1}} | |||
m |
|
12:47 (cur | prev) +20 Jwarner talk contribs |